Enjoy this podcast with Leonard Mazur, the co-founder, Chairman, and CEO of Citius Pharmaceuticals, a late-stage biopharma company focused on developing critical care. With over 50 years in the industry, there are many success lessons to be learned as Leonard has co-founded several companies, including Akrimax Pharmaceuticals and Genesis Pharmaceuticals, which he successfully sold to Pierre Fabre in 2003. DisclaimerThe information contained in this website and podcast arepurely informational and not considered investment recommendations. Tim Dougherty’s participation in Biotech Insights is separate and apart from his role as an investment advisor representative. Nothing contained herein may beconstrued as a recommendation or endorsement of any of the companies discussed.Tim Dougherty has no financial affiliation with any of the companies mentioned in this communication. Tim Dougherty makes no representation that the information conveyed in this material is accurate and is under no obligation to update this information as changes occur.
--------
41:41
He’s setting the world of Inflammation and Immunology research on fire!
Today we are honored to have Dr. Josep Bassaganya-Riera, President and CEO of NImmune Biopharma, to talk about how his company is leveraging computational modeling and bioinformatics to develop new therapeutics.DisclaimerThe information contained in this website and podcast are purely informational and not considered investment recommendations. Tim Dougherty’s participation in Biotech Insights is separate and apart from his role as an investment advisor representative. Nothing contained herein may be construed as a recommendation or endorsement of any of the companies discussed. Tim Dougherty has no financial affiliation with any of the companies mentioned in this communication. Tim Dougherty makes no representation that the information conveyed in this material is accurate and is under no obligation to update this information as changes occur.
--------
48:10
Patient Advocacy is NOT optional!
In this podcast, we are pleased to have Mike Walsh, CEO of Patient Advocacy Strategies as our guest. Patient advocacy may seem like a “nice to have” or an afterthought. In this podcast you’ll learn why the opposite is true – that it’s important to glean input from patient groups early on in the lifecycle and throughout the course of developing solutions for patients. Disclaimer The information contained in this website and podcast are purely informational and not considered investment recommendations. Tim Dougherty’s participation in Biotech Insights is separate and apart from his role as an investment advisor representative. Nothing contained herein may be construed as a recommendation or endorsement of any of the companies discussed. Tim Dougherty has no financial affiliation with any of the companies mentioned in this communication. Tim Dougherty makes no representation that the information conveyed in this material is accurate and is under no obligation to update this information as changes occur.
--------
45:55
Taming the Behemoth of Adverse Drug Reactions with Zach Brooks
It’s shocking that 106,000 people die every year from adverse drug reactions. Moreover, 350,000 people are hospitalized every year, 1.3 million people go to the ER, and it is the fourth leading cause of death in the United States. Adverse drug reactions are a behemoth problem, costing the economy almost half trillion dollars.DisclaimerThe information contained in this website and podcast are purely informational and not considered investment recommendations. Tim Dougherty’s participation in Biotech Insights is separate and apart from his role as an investment advisor representative. Nothing contained herein may be construed as a recommendation or endorsement of any of the companies discussed. Tim Dougherty has no financial affiliation with any of the companies mentioned in this communication. Tim Dougherty makes no representation that the information conveyed in this material is accurate and is under no obligation to update this information as changes occur.
--------
53:06
A cup of Kombucha that ignited the war on sugar addiction
In this episode, filed at Science Square in Atlanta, we speak with David Francis and Mighten Yip of Palate Therapeutics, whose mission is to alter people’s food preferences away from sugary foods using therapeutic mouthwash.
Disclaimer
The information contained
in this website and podcast are purely informational and not considered
investment recommendations. Tim Dougherty’s participation in Biotech Insights
is separate and apart from his role as an investment advisor representative. Nothing
contained herein may be construed as a recommendation or endorsement of any of
the companies discussed. Tim Dougherty has no financial affiliation with any of
the companies mentioned in this communication. Tim Dougherty makes no
representation that the information conveyed in this material is accurate and
is under no obligation to update this information as changes occur.
In this podcast we’ll hear life science and biotech CEOs tell their stories about their experiences launching and growing a biotech firm. We publish a quarterly newsletter on our biotech podcasts as well as other entrepreneurial insights. Please subscribe here: http://eepurl.com/h6Gwa5
Be ready for motivating stories of grit and determination, along with practical tips, strategies, and guidance from some of the leading minds in the field. Hosted by portfolio manager Tim Dougherty, episodes will be available on the third Wednesday of the month over Spotify.
UK